Breast Cancer Clinical Trial
Official title:
BRE-WL4AA Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors
This is a randomized intervention study to examine the effects of the Moving Forward Guided Weigh Loss Intervention compared to a self-guided weight loss program on BMI and behavioral, biological, and psychosocial outcomes in overweight and obese African American women diagnosed with Stage I, II, or III breast cancer.
This is a randomized study with 300 African American (AA) breast cancer survivors to be
conducted in Chicago Park District (CPD) facilities. The study will be based in six
predominantly AA communities in Chicago (Roseland, Pullman, Englewood, Chatham, Austin, South
Shore, Woodlawn, Calumet Heights, North Lawndale and Grand Crossing). These communities have
at least one CPD fitness center, have populations that are at least 90% or more AA and have
similar socioeconomic statuses. Fifty AA breast cancer survivors will be recruited from each
community (25 treatment/ 25 control).
The Moving Forward intervention integrates concepts from Social Cognitive Theory (SCT) and
the Socio-Ecological Model (SEM) to promote independent behavior change. SCT suggests that
behavior can be explained by the dynamic interaction between behavior, personal factors
(e.g., self-efficacy), and the environment (e.g, social support). Self-efficacy is a person's
confidence in performing a particular behavior and overcoming barriers to that behavior. A
number of studies have supported the mediating role of self-efficacy in making independent
health behavior changes.
The overall goal of Moving Forward is to make independent changes in health behaviors to
promote a healthy weight. The weight loss goal will be consistent with the recommendations of
an expert panel at National Institutes of Health (NIH). Dietary goals aimed at producing
weight loss, decreasing BC recurrence risk, and improving overall health include 1) a
decrease in daily caloric intake (based on weight in pounds X 12 kcal/day with 500-750
calories subtracted to create an energy deficit); 2) a decrease in dietary fat consumption to
20% of total calories; 3) an increase in fruit and vegetable consumption to 7 daily servings;
and 4) an increase in fiber to 25 grams per day. For exercise, participants will gradually
increase their activity to a minimum of 180 minutes per week at 55-65% maximal heart rate.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |